Leaflet FIBROVEIN 3% solution for injection


Indicated for: constipation

Route of administration: injectable

Substance: sodium tetradecyl sulfate (laxative)

ATC: C05BB04 (Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection)

Sodium tetradecyl sulfate is a sclerosing agent used in the treatment of varicose veins and reticular veins. It works by irritating the venous wall, causing the vein to collapse and close.

The medication is administered as an injection directly into the affected vein, as directed by a doctor. It is important for the procedure to be performed by a specialist to minimize risks.

Patients should be aware of potential side effects, such as local pain, inflammation, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local pain, inflammation, and skin discoloration. In rare cases, severe reactions such as deep vein thrombosis or anaphylactic reactions may occur. Patients should be informed of these risks before treatment.

General data about FIBROVEIN 3%

  • Substance: sodium tetradecyl sulfate
  • Date of last drug list: 01-05-2026
  • Commercial code: W67006001
  • Concentration: 3%
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: generic
  • Price: 259.47 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MEDIPHA SANTE - FRANTA
  • Holder: STD PHARMACEUTICAL (IRELAND) LIMITED - IRLANDA
  • Number: 10790/2018/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Concentrations available for sodium tetradecyl sulfate

  • 0.2%
  • 0.5%
  • 1%
  • 3%